Product
Efbemalenograstim
1 clinical trial
2 indications
Indication
Ovarian CancerIndication
Cervical CancerClinical trial
A Study of Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen With Risk Factors:A Single-Arm, Multicenter Clinical TrialStatus: Recruiting, Estimated PCD: 2026-06-01